Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion type Assertion NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_head.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion description "[In conclusion, we uncovered an ALK-specific regulation of the hypoxia response across different ALK(+) tumor types and propose HIFs as a powerful specific therapeutic target in ALK-rearranged ALCL and NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_provenance.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion evidence source_evidence_literature NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_provenance.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion SIO_000772 25193384 NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_provenance.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion wasDerivedFrom befree-2016 NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_provenance.
- NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_assertion wasGeneratedBy ECO_0000203 NP1217387.RA2BIZpgc_EsQ0n7w76Hl7j-x4xjXv0R4gGQJZIQvP_Nc130_provenance.